Firefly Bio Debuts With $94 Million Series A Financing
— Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company — February 15, 2024 08:00 AM Eastern Standard Time SOUTH SAN…